| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 08/28/2001 | US6281212 Chemokine receptor antagonists and methods of use therefor |
| 08/28/2001 | US6281206 Amidino and benzamidino compounds |
| 08/28/2001 | CA2017252C Retroviral protease inhibiting compounds |
| 08/23/2001 | WO2001060803A1 Fused imidazolium derivatives |
| 08/23/2001 | WO2001007029A3 Substituted guanidines and the use thereof |
| 08/23/2001 | WO2000071508A3 Inhibitors of factor Xa |
| 08/23/2001 | US20010016659 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/23/2001 | US20010016207 Compounds such as N-(1-(cyanomethylcarbamoyl)cyclohexyl)-4-(piperazin-1-yl)-benzamide |
| 08/23/2001 | DE10005631A1 Arginin-Mimetika als Faktor X¶a¶-Inhibitoren Arginine mimetics as inhibitors of factor X¶a¶ |
| 08/22/2001 | EP1125582A2 Use of estrogen agonists / antagonists for the treatment of sexual dysfunction |
| 08/22/2001 | EP1124797A1 N-arylsulfonyl amino acid omega amides |
| 08/22/2001 | EP1124795A1 Inhibitors of the egf-receptor tyrosine kinase and their use |
| 08/22/2001 | EP1124552A1 Antitumor chrysene derivatives |
| 08/22/2001 | EP0960093B1 Method for hydrogenating compounds from the group of imines or enamines |
| 08/22/2001 | CN1309690A Amine reaction compounds comprising one or more active ingredient |
| 08/22/2001 | CN1309654A Biphenyl derivs. |
| 08/22/2001 | CN1309634A Hydrazine derivs. |
| 08/22/2001 | CN1309116A Cyclic amine substd. phenylalkanone and preparing method thereof |
| 08/21/2001 | US6277987 Sulfonylamino acid and sulfonylamino hydroxamic acid derivatives |
| 08/21/2001 | US6277897 Photoinitiators and applications therefor |
| 08/21/2001 | US6277840 Antiinflammatory agents |
| 08/21/2001 | CA2236940C Processes and intermediates for preparing 3-(1-piperazinyl)-1,2-benzisothiazole |
| 08/21/2001 | CA2205555C Use of nitric oxide-releasing agents for reducing metastasis risk |
| 08/21/2001 | CA2196845C Hydroxamic acid compounds |
| 08/16/2001 | WO2001059067A2 A group of anti-cancer compounds with specific structure and their production method |
| 08/16/2001 | WO2001059000A1 New 3-arylbenzofuranones with electron-withdrawing substituents as stabilizers |
| 08/16/2001 | WO2001058886A1 Dipeptide nitrile cathepsin k inhibitors |
| 08/16/2001 | WO2001058859A1 ARGININE MIMETICS AS FACTOR Xa INHIBITORS |
| 08/16/2001 | WO2001058855A1 Use of androgen receptor suppressors |
| 08/16/2001 | WO2001058854A1 A topical antiandrogen for hair loss and other hyperandrogenic conditions |
| 08/16/2001 | WO2001010842A3 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 08/16/2001 | WO2001007435A3 N-(indolcarbonyl-)piperazin derivatives als 5-ht2a-receptor ligands |
| 08/16/2001 | EP1123926A1 Piperazine derivatives for treatment of CNS disorders |
| 08/16/2001 | EP1123918A1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same |
| 08/16/2001 | EP1123276A1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 08/16/2001 | EP0704439B1 Novel intermediate for synthetic use and process for producing aminopiperazine derivative |
| 08/16/2001 | CA2400063A1 New 3-arylbenzofuranones with electron-withdrawing substituents as stabilizers |
| 08/16/2001 | CA2398923A1 A group of anti-cancer compounds with specific structure and their production method |
| 08/15/2001 | CN1308608A Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
| 08/15/2001 | CN1308606A Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use pharmaceutical preparations comprising them |
| 08/15/2001 | CN1308604A 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1308602A Method for purifying hexamethylenediamine in mixtures of hexamethylenediamine and an unsaturated cyclic imine |
| 08/15/2001 | CN1308534A Angiogenesis inhibitors |
| 08/14/2001 | US6274618 Administering (-)-cis-6-phenyl-5-(4-(2-pyrrolidin-1-yl-ethoxy)-phenyl)-5,6,7,8 -tetrahydronphthalen-2-ol to treat vaginal dryness, itching, or painful intercourse |
| 08/14/2001 | US6274588 4-phenyl-pyrimidine derivatives |
| 08/14/2001 | US6274583 Alpha 1a adrenergic receptor antagonists |
| 08/14/2001 | US6274336 Producing three-dimensional structure of active site using computer program, displaying and superimposing three-dimensional representation of test compound onto active site, preparing test compound, and testing in biological assay |
| 08/14/2001 | CA2159640C Second messenger cell signaling inhibitors |
| 08/14/2001 | CA2158484C Novel benzopyrane derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/09/2001 | WO2001057947A1 Use of amidines |
| 08/09/2001 | WO2001057008A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| 08/09/2001 | WO2001056989A2 Inhibitors of factor xa |
| 08/09/2001 | WO2001056979A1 Substituted cyanoacetamide derivatives and herbicides |
| 08/09/2001 | WO2001056974A2 Inha inhibitors and their use as antibacterials |
| 08/09/2001 | WO2001056563A1 Adamantyl derivatives as anti-cancer agents |
| 08/09/2001 | WO2001010834A9 Antibacterial agents |
| 08/09/2001 | WO2000071511A3 INHIBITORS OF FACTOR Xa |
| 08/09/2001 | WO2000059878A3 INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF |
| 08/09/2001 | WO2000047554A3 INHIBITORS OF FACTOR Xa |
| 08/09/2001 | US20010012857 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 08/09/2001 | US20010012848 An indane-like compounds which can be useful for treating psychosis and other conditions associated with modulation of a muscarinic receptor |
| 08/09/2001 | DE10004928A1 Use of perfluorinated two-five carbon carboxylic acid amides as solvent (component) for salt conductors in electrolytes, e.g. for rechargeable batteries |
| 08/09/2001 | CA2398754A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| 08/08/2001 | EP1122242A1 Cyanophenyl derivatives |
| 08/08/2001 | EP1121342A1 Diaminopropionic acid derivatives |
| 08/08/2001 | EP1121118A1 Formamides as therapeutic agents |
| 08/08/2001 | CN1307563A N-phenyl-N'-phenylpropylpiperazine derivatives and process for the preparation thereof |
| 08/08/2001 | CN1069356C Process for purifying tertiary aminoxide aqueous solution |
| 08/07/2001 | US6271395 Substituted with an N-methyl benzene-acetamide and 1-pyrrolidinyl |
| 08/07/2001 | US6271235 HIV protease inhibitors |
| 08/07/2001 | CA2297944A1 The groups with anticancer activity and the method of making their derivatives |
| 08/02/2001 | WO2001055125A1 A process for the preparation of quetiapine and intermediates therefor |
| 08/02/2001 | WO2001055111A1 Biaryl compounds, their preparation and their use in therapy |
| 08/02/2001 | WO2001054691A1 Nitrate salts of antimicrobial agents |
| 08/02/2001 | WO2000076971A3 Serine protease inhibitors |
| 08/02/2001 | WO2000066175A3 Conjugates as therapies for cancer and prostate diseases |
| 08/02/2001 | US20010011136 Anticancer agents |
| 08/02/2001 | US20010011135 Anticancer agents |
| 08/02/2001 | US20010011093 Arylgycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 08/02/2001 | CA2397754A1 Nitrate salts of antimicrobial agents |
| 08/01/2001 | EP1120410A1 Nicotinic acid esters useful as CNS agents and having affinity for 5-HT receptors |
| 08/01/2001 | EP1120114A2 Compositions and methods for treating conditions responsive to estrogen |
| 08/01/2001 | EP0877737B1 Novel n-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity |
| 08/01/2001 | CN1306526A Novel heterocyclically substituted amides with cysteine protease-inhibiting effect |
| 08/01/2001 | CN1306509A Substituted benzamides, their prodn. and use as cysteine protease inhibitors |
| 08/01/2001 | CN1306505A Substituted benzamides, their prodn. and use |
| 08/01/2001 | CN1306428A Inhibitors of transcription factor NF-KB |
| 08/01/2001 | CN1305989A Benzene sulfonamide compounds, its preparing method and medicinal compsns. contg. same |
| 08/01/2001 | CN1305812A N-(aryloxy group alkyl) heteroaromatic guadine and heteroaromatic guazine used as medicines |
| 07/31/2001 | US6268504 Aryloxy-alkyl-dialkylamines |
| 07/31/2001 | US6268367 Piperazine derivatives for treating bone deficit conditions |
| 07/31/2001 | US6268361 Estrogen dependent disorders including cancer, enodmetriosis, etc |
| 07/26/2001 | WO2001053280A1 Substituted phenylamidines medicaments containing said compounds and method for production thereof |
| 07/26/2001 | WO2001053279A1 Urea compounds as inhibitors for vla-4 |
| 07/26/2001 | WO2001053260A1 Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion |
| 07/26/2001 | WO2001053258A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 07/26/2001 | WO2000018750A9 Chelates comprising chinoid groups as photoinitiators |
| 07/26/2001 | US20010009962 One pot process for preparing sildenafil (drug for erectile dysfunction) and derivatives by reacting for example 4-(2-methoxy-5-(4-methyl-1-piperazinylsulfonyl)benzamido)-1-methyl-3-propyl -1H-pyrazole-5-carboxamide with ethanol |
| 07/26/2001 | US20010009915 Nitrogen oxide yielding and thromboxane A2 (TXA2) and serotonin (5HT2) receptor antagonist; treatment of atherothrombotic cardiovascular disorders |
| 07/26/2001 | DE10002510A1 New phenylamidine compounds are useful for the treatment of thrombosis, cerebrovascular disorders, heart infarction, arteriosclerosis, osteoporosis, tumor metastasis, shock and diabetes |